Connection

Carol Feghali-Bostwick to Insulin-Like Growth Factor Binding Protein 3

This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Insulin-Like Growth Factor Binding Protein 3.
  1. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS One. 2012; 7(8):e43049.
    View in: PubMed
    Score: 0.394
  2. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum. 2012 Jan; 64(1):272-80.
    View in: PubMed
    Score: 0.378
  3. Role of insulin-like growth factor binding protein-3 in allergic airway remodeling. Am J Respir Crit Care Med. 2009 Oct 01; 180(7):611-7.
    View in: PubMed
    Score: 0.318
  4. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol. 2005 Feb; 166(2):399-407.
    View in: PubMed
    Score: 0.234
  5. Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. J Cell Mol Med. 2011 Apr; 15(4):957-69.
    View in: PubMed
    Score: 0.090
  6. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am J Pathol. 2006 Nov; 169(5):1633-42.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.